BridgeBio Pharma (NASDAQ:BBIO) Now Covered by Analysts at Cowen
Cowen assumed coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Rating) in a research report report published on Monday morning, The Fly reports. The brokerage issued an outperform rating on the stock. BBIO has been the subject of a number of other research reports. JPMorgan Chase & Co. reduced their price objective on BridgeBio […]